Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Head & Neck 1Endocrine 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 17Melanoma 15Head and Neck Neoplasms 15Carcinoma, Renal Cell 12Carcinoma, Non-Small-Cell Lung 12Stomach Neoplasms 8Uterine Cervical Neoplasms 7Neoplasms 7Colorectal Neoplasms 7Carcinoma, Transitional Cell 6Carcinoma, Hepatocellular 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Carcinoma, Merkel Cell 5Pancreatic Neoplasms 4Ovarian Neoplasms 4Kidney Neoplasms 4Carcinoma, Squamous Cell 4Breast Neoplasms 4Small Cell Lung Carcinoma 3Esophageal Neoplasms 3Urogenital Neoplasms 2Thyroid Carcinoma, Anaplastic 2Sarcoma 2Oropharyngeal Neoplasms 2Nasopharyngeal Carcinoma 2Microsatellite Instability 2Mesothelioma, Malignant 2Mesothelioma 2Gastrointestinal Neoplasms 2

Interventions

Specimen Handling 2Radiotherapy 2Magnetic Resonance Spectroscopy 2tipifarnib 1pentetreotide 1lutetium Lu 177 dotatate 1gallium Ga 68 dotatate 1fostamatinib 1fluorodopa F 18 1fludarabine phosphate 1cabozantinib 1atezolizumab 1Tamoxifen 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Octreotide 1Nivolumab 1Molecular Diagnostic Techniques 1Ipilimumab 1Interleukin-13 1Indinavir 1Immunotherapy 1Genetic Testing 1Fluorodeoxyglucose F18 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Cryosurgery 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pheochromocytoma × atezolizumab × Head & Neck × Clear all
NCT04400474 2025-06-19

CABATEN

Grupo Espanol de Tumores Neuroendocrinos

Phase 2 Completed
93 enrolled 17 charts
CNSEndocrineHead & NeckNET

Adenocarcinoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors, Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡